We used an RNA interference (RNAi) library in a forward genetic selection to study the mechanism of toxicity of tubercidin (7-deazaadenosine) to procyclic Trypanosoma brucei. Following transfection of cells with an RNAibased genomic library, we used 5 M tubercidin to select a drug-resistant cell line. Surprisingly, we found in these resistant cells that the hexose transporters had been silenced. We subsequently found that silencing of hexokinase, a glycolytic enzyme, also yielded tubercidinresistant parasites. These observations suggested that glycolysis could be a target of tubercidin action and that RNAi silencing of glycolytic enzymes was gradual enough to allow the parasites to adapt to alternative sources of energy. Indeed, adaptation of procyclic trypanosomes to a glucose-independent metabolism by reduction of glucose in the culture medium caused tubercidin resistance. High pressure liquid chromatography analysis of glycolytic intermediates from parasites treated with tubercidin showed a dose-dependent increase in concentration of 1,3-bisphosphoglycerate, a substrate of phosphoglycerate kinase. Furthermore, tubercidin triphosphate inhibited recombinant T. brucei phosphoglycerate kinase activity in vitro with an IC 50 of 7.5 M. We conclude that 5 M tubercidin kills trypanosomes by targeting glycolysis, especially by inhibition of phosphoglycerate kinase.
We used an RNA interference (RNAi) library in a forward genetic selection to study the mechanism of toxicity of tubercidin (7-deazaadenosine) to procyclic Trypanosoma brucei. Following transfection of cells with an RNAibased genomic library, we used 5 M tubercidin to select a drug-resistant cell line. Surprisingly, we found in these resistant cells that the hexose transporters had been silenced. We subsequently found that silencing of hexokinase, a glycolytic enzyme, also yielded tubercidinresistant parasites. These observations suggested that glycolysis could be a target of tubercidin action and that RNAi silencing of glycolytic enzymes was gradual enough to allow the parasites to adapt to alternative sources of energy. Indeed, adaptation of procyclic trypanosomes to a glucose-independent metabolism by reduction of glucose in the culture medium caused tubercidin resistance. High pressure liquid chromatography analysis of glycolytic intermediates from parasites treated with tubercidin showed a dose-dependent increase in concentration of 1,3-bisphosphoglycerate, a substrate of phosphoglycerate kinase. Furthermore, tubercidin triphosphate inhibited recombinant T. brucei phosphoglycerate kinase activity in vitro with an IC 50 of 7.5 M. We conclude that 5 M tubercidin kills trypanosomes by targeting glycolysis, especially by inhibition of phosphoglycerate kinase.
Trypanosoma brucei is the parasite that causes sleeping sickness, an important disease in Africa. Trypanosomes have complex life cycles with developmental stages in the mammalian host and the tsetse fly vector. T. brucei undergoes dramatic changes in metabolism linked to its development. Bloodstream form trypanosomes residing in the mammalian bloodstream lack a Krebs cycle and electron transport chain. They take advantage of the constant supply of blood glucose to generate ATP exclusively through glycolysis. Procyclic form parasites in the tsetse midgut experience a range of nutrient environments and have a more opportunistic metabolism. They utilize glucose or amino acids as carbon and energy sources (1) .
We have described a genomic RNAi 1 library for forward genetic analysis in T. brucei (2) . For these experiments, we inserted fragments of sheared T. brucei DNA into the RNAi vector pZJM␤ in which the insert is flanked by T7 promoters under the control of tetracycline operators. We stably integrated this library of genomic fragments into a transgenic procyclic form T. brucei cell line that expresses the tet repressor and T7 RNA polymerase (3). Expression of dsRNA from the opposing promoters is induced upon the addition of tet to the culture medium with concomitant degradation of the corresponding mRNA via the endogenous RNAi pathway.
In this study, we were interested in identifying genes whose silencing conferred resistance to the toxic adenosine analog tubercidin (7-deazaadenosine, Tu). Although mutants deficient in adenosine transport in Leishmania are resistant to Tu (4), little is known regarding the molecular basis of its toxicity. In mammalian cells, Tu is a substrate for adenosine kinase and becomes incorporated into RNA and DNA (5) . In an attempt to discover the target of Tu in T. brucei, we screened the RNAi genomic library to select for Tu-resistant cells. To our surprise, we found that silencing of the hexose transporter resulted in Tu resistance. Additionally, RNAi silencing of a glycolytic enzyme or pre-adaptation of parasites to low glucose medium yields Tu-resistant cells. These data suggest that Tu toxicity in trypanosomes is because of its impact on glycolysis, and we have identified phosphoglycerate kinase as a glycolytic enzyme that is inhibited by Tu. Trypanosome Growth and Transfection-Procyclic T. brucei 29 -13 (a gift from Drs. Elizabeth Wirtz and George Cross), which expresses T7 RNA polymerase and the tet repressor, was grown in SDM-79 supple-mented with 15% fetal bovine serum, G418 (15 g/ml), and hygromycin (50 g/ml) (3). For growth in low glucose conditions, trypanosomes were first adapted (for 7 days) to "low glucose medium" (SDM-79 with minimal essential medium replaced by RPMI 1640 medium without glucose (Invitrogen)). This medium also lacked the additional glucose and glucosamine found in standard SDM-79, but it was supplemented with 50 mM proline and 10% fetal bovine serum. The cells were then transferred to "minimal glucose medium" (same as low glucose medium with the exception that dialyzed fetal bovine serum (10%) was used). Transfection of the pZJM library was performed as described previously (2) .
EXPERIMENTAL PROCEDURES
Tubercidin Selection and Analysis of the pZJM Insert-The adenosine analog tubercidin (7-deazaadenosine) is toxic to procyclic trypanosomes with an EC 50 (the effective concentration causing 50% reduction in cell growth after 48 h) of 0.5 M (Fig. 1) . To select for Tu-resistant trypanosomes, we induced 50 ml of culture at 1 ϫ 10 6 cells/ml with 1 g/ml tet for 5 days and then added 5 M Tu to the culture medium.
Most cells died within 7 days, and survivors were cloned by limiting dilution in 96-well plates under 5% CO 2 at 26°C. Once the wells became visibly turbid, cells were transferred to flasks, grown to a density of ϳ1 ϫ 10 6 cells/ml, and harvested by centrifugation. Genomic DNA was then isolated using a DNA purification kit (Gentra Systems, Minneapolis, MN), and PCR was performed using primers XlinkF (5Ј-CTC-GAGGGCCAGTGAGGC-3Ј) and HlinkR (5Ј-AGCTTGGCCTGTGAG-GCC-3Ј) to amplify the unknown fragment within pZJM␤.
The PCR product was cloned into pCR2.1-TOPO (Invitrogen), sequenced, and analyzed by BLAST searches. As discussed under "Results," we found the insert to be a fragment of the trypanosome hexose transporter (THT) gene. To confirm that RNAi of THT could confer Tu resistance, we cloned a 350-bp fragment of the open reading frame of THT1e (GenBank TM accession number X69091) by PCR of T. brucei genomic DNA using primers THT5ЈF (5Ј-CACATCACCGGGTTTCTTC-T-3Ј) and THT5ЈR (5Ј-TGCACTTCCCGGCTATAATC-3Ј). This fragment does not overlap with the fragment recovered from the library in Tu-resistant cells and leads to the silencing of both THT1 and THT2 family members. The T. brucei hexokinase 1 gene was silenced using a 500-bp fragment of the open reading frame of T. brucei hexokinase 1 gene (GenBank TM accession number AJ345044). To obtain this fragment, we performed PCR on T. brucei genomic DNA using primers HK2F (5Ј-CCTTCTTCAGGCTGCTTTTG-3Ј) and HK2R (5Ј-GAAC-TGAAGTCCGGGCATAC-3Ј).
Kinetic Analysis of Glucose Uptake-Glucose transport was assayed by a rapid oil-stop method (6) . Cells were washed once with PBS and resuspended in PBS to a density of 5 ϫ 10 7 cells/ml, and 100 l were layered over 200 l of a mixture of dibutylphthalate and light mineral oil (95:5 v/v) in a 1.5-ml Microfuge tube. To initiate uptake, 100 l of PBS containing 10 M [ 3 H]2-deoxyglucose were added to the Microfuge tube. To stop the reaction, cells were separated from assay buffer by centrifugation (1 min, 12,000 ϫ g) through the oil. The oil/cell pellet was washed twice with 200 l of PBS, and then the cells were lysed in 0.1 ml of 10% Triton X-100. Scintillation fluid was added, and radioactivity was counted in a scintillation counter. Reactions were performed at 22°C in triplicate.
Northern Blotting and Hybridization-Total RNA was purified from 5 ϫ 10 6 parasites (Purescript RNA Isolation Kit, Gentra Systems) and electrophoresed on formaldehyde-1.5% agarose gels as described previously (7). Ribosomal RNA was estimated by ethidium bromide staining to ensure equal loading of RNA in each lane. Percent reduction of mRNA levels induced by RNAi was estimated by densitometry of appropriately exposed autoradiograms.
Uptake Assays of THT Expressed in Xenopus
Oocytes-THT open reading frames were subcloned into the EcoRI site of the Xenopus expression vector pL2-5 (8), linearized, and in vitro transcribed with T7 RNA polymerase (Invitrogen) in the presence of CAP analog (m 7 G(5Ј)G) (Ambion) as described previously (9) . Stage V-VI oocytes were injected with 23 nl of complementary RNA (ϳ10 ng), incubated in ND96 buffer for 3 days at 16°C as described previously (9), and used for uptake assays. Oocytes injected with complementary RNA or water as control were incubated for 3 days after injection. Prior to the assay, the oocytes were incubated for 30 min in ND96 buffer at room temperature. The uptake of 10 M [ 3 H]tubercidin was assayed by incubating oocytes with radiolabeled substrate for 1 h followed by three quick washes in cold ND96 buffer. Uptake was determined by liquid scintillation counting as described previously (10) .
HPLC of Glycolytic Intermediates-Cells (10 ml, 1 ϫ 10 7 /ml) were harvested during log-phase growth, washed in ice-cold 10 mM Tris-HCl, pH 7.4, and resuspended in boiling H 2 O at 10 9 cells/ml for 5 min. The lysate was chilled on ice for 10 min and cleared by centrifugation (16,000 ϫ g, at 4°C for 10 min), and 50 l of the final extract was chromatographed on a Dionex BioLC fitted with a 4-mm AS11 column and guard and a pulsed amperometric detector. A 40-min run with a flow rate of 2 ml/min was initiated at 2 mM NaOH. Eluant concentrations were increased linearly, reaching the following concentrations at the times indicated: 12 mM NaOH (15 min); 20 mM NaOH (25 min); 70 mM NaOH (35 min); 2 mM NaOH (35.1 min); and 2 mM NaOH (with a return to base line by 40 min).
Purification and Characterization of Recombinant Phosphoglycerate Kinase-PCR was used to amplify the T. brucei phosphoglycerate kinase B (PGKB) open reading frame from a plasmid carrying the T. brucei PGKB gene (pTbPGKB, a generous gift from Dr. Paul Michels, Catholic University of Louvain, Brussels, Belgium) using primers PGKfor (5Ј-ATGTCACTAAAAGAGAGGAA-3Ј) and PGKrev (5Ј-CTCCTTAT-CATCCAATACTG-3Ј). The PCR product was cloned into the expression vector pBAD-TOPO to yield pBAD-TOPO-PGKB. Expression from this vector generates a C-terminal His 6 tag fusion protein. Top10 Escherichia coli (Invitrogen) harboring pBAD-TOPO-PGKB was induced to express PGKB by the addition of arabinose (0.02%) for 4 h at room temperature. Cells were harvested and washed in lysis buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 10 mM imidazole) and lysed by the addition of lysozyme (100 g/ml) on ice for 15 min followed by sonication (3 ϫ 10 s at full power using a Branson sonicator) and two rounds of freeze-thaw by immersion in a dry-ice/EtOH and 37°C bath. The lysate was centrifuged (15 min, 3,000 ϫ g), and the supernatant was applied to a nickel-nitrilotriacetic acid column (Quiagen) pre-equilibrated with lysis buffer. The column was washed with five column volumes of lysis buffer containing 1 mM ATP, two column volumes of wash buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 20 mM imidazole, 1 mM ATP), and protein eluted with two column volumes of elution buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 250 mM imidazole). The protein was judged to be 99% pure by Coomassie Bluestained SDS-PAGE.
Coupled PGK activity assays were performed as described previously (11) using a Beckman DU-640 to monitor the change in absorbance at 340 nm. Recombinant PGKB had a specific activity of 222 units/mg, similar to that observed for recombinant PGKB lacking a His tag (11) . A unit is the amount of enzyme required to convert 1 mol substrate/ min. Inhibitors were preincubated with enzyme for 10 min on ice prior to initiation of the reaction.
Synthesis and Purification of Tubercidin Triphosphate-TuTP was synthesized from commercially available TuMP using a protocol adopted from Schobert (12) . TuMP (10 mol) was incubated (15 h, 30°C) in a 1-ml reaction consisting of 0.2 M triethanolamine, pH 7.6, 100 mM KCl, 50 mM MgSO 4 , 1 mol of inosine triphosphate, 1 unit of nucleoside monophosphate kinase, 20 units of pyruvate kinase, and 30 mol of phosphoenolpyruvate. The pH was adjusted to 7.6 with NaOH. TuTP was purified from the reaction components using an isocratic purification on a C 18 reverse-phase 2.1 ϫ 150 mm column (25°C, 125 l/min, Grace Vydac, Hesperia, CA) using the SMART System (Amersham Biosciences). The products were resolved using buffer A (2 mM tributylamine, 0.09 M NH 4 HCO 3 , 2% CH 3 CN). TuTP fractions were dried and washed three times by the addition of 50 l of H 2 O followed by the addition of 50 l of 100% EtOH and evaporation to dryness under N 2 .
TuTP was characterized by mass spectrometry. The sample was diluted into 1% acetic acid, 35% methanol and sprayed at a flow rate of 1 l/min directly into a Thermofinnigan LCQ ion trap mass spectrometer, and the spectra were recorded from m/z 300 to 700. The m/z for the protonated form of TuTP was 507. Most of the ions corresponded to TuTP, but there were detectable ions of TuDP (m/z 427) and TuMP (m/z 347). All of the observed m/z values agree with calculated values.
RESULTS

Selection of Tubercidin-resistant Trypanosomes Using an
RNAi Library-To achieve random silencing of T. brucei gene expression, we transfected enough trypanosomes to achieve a 5-fold coverage of the genome. Following selection for stably transfected parasites with phleomycin, we induced the cells to express dsRNA by the addition of tet, and after 5 days, we added 5 M Tu, a concentration ϳ10-fold higher than the EC 50 of WT cells (Fig. 1A) . Resistant parasites, evident after 10 days, were cloned by limiting dilution.
We identified the sequences responsible for Tu resistance by purifying DNA from the cloned cells and amplifying the pZJM␤ inserts using primers flanking the multicloning site. Six of the ten clones sequenced contained a 785-bp fragment that was 100% identical to the 3Ј end of the coding region of the gene encoding the trypanosome hexose transporter THT1 (Fig. 2A) . The remaining four clones, not containing an open reading frame, were not studied further.
To confirm that RNAi of THT1 confers resistance to Tu, we cloned the THT fragment into pZJM and transfected the construct into 29-13 cells, yielding the pZJM(THT-3Ј) cell line. If uninduced, this cell line has an EC 50 of 0.84 Ϯ 0.09 M for Tu, similar to that of WT cells (Fig. 1A) . However, following induction of RNAi for 7 days, these cells became more resistant to Tu with an EC 50 of 4.55 Ϯ 0.27 M. Furthermore, tetracyclineinduced pZJM(THT-3Ј) cells grown in the presence of 5 M Tu have a doubling time comparable with that of the 29-13 parental cell line in the absence of Tu (Fig. 1B) with no evident morphological phenotype after two months of continuous growth in 5 M Tu.
RNA Interference of the Trypanosome Hexose Transporter-
THT1 is a member of an 11-gene cluster consisting of six tandem THT1 genes followed by five tandem THT2 genes (the exact copy number depends on the strain) (13) . With the exception of ϳ180 bp, which distinguishes the two families ( Fig. 2A , hatched region), these two gene families share a ϳ80% sequence identity over their coding region (Fig. 2A) .
Although we identified a THT1 fragment in our screen, procyclic trypanosomes express predominately THT2 (13) . We hypothesized that the high sequence identity between the two genes would result in reduction of mRNA for both types of genes in the pZJM(THT-3Ј) cell line. To test this hypothesis, we performed Northern blots using probes specific for THT1 and THT2. After 40 h of tet induction, THT1 mRNA is reduced by Ͼ90% and THT2 mRNA is nearly undetectable (Fig. 2B) . Furthermore, we confirmed that the THT gene products were reduced by performing 2-deoxyglucose uptake assays. Compared with parental cells, RNAi in the pZJM(THT-3Ј) cell line causes dramatic reduction of 2-deoxyglucose uptake (Fig. 2C) . RNAi using a 350-bp fragment corresponding to a different region of the THT coding sequence (see "Experimental Procedures") also yielded Tu-resistant cells exhibiting severely reduced glucose uptake (data not shown).
Does the Glucose Transporter Transport Tubercidin?-The simplest hypothesis to explain how silencing of THT confers Tu resistance is that THT is involved directly in Tu uptake, possibly as a low affinity transporter. To address this question, we expressed THT1 and THT2 in Xenopus oocytes (Table I) . As expected, significant levels of glucose were transported upon expression of either gene. However, we could detect no measurable uptake of [ Tubercidin Resistance Is Conferred by RNAi of Glycolytic Activity-A second hypothesis to explain the role of THT in Tu resistance is that Tu affects glucose metabolism. The first enzyme in glycolysis, hexokinase, converts glucose to glucose 6-phosphate. To test whether silencing of hexokinase would also confer Tu resistance, we transfected cells with pZJM containing a fragment of the T. brucei hexokinase gene using the construct pZJM(HKORF) (2) . Upon induction of RNAi, these cells also became resistant to Tu (EC 50 , ϳ10 M, data not shown), suggesting that a step in glycolysis might be targeted by Tu.
Therefore, we conducted an experiment based on the finding that procyclic trypanosomes can suppress glycolysis and rely instead on amino acids as a carbon and energy source (14) . Parental cells were adapted to amino acid metabolism by growth on low glucose medium for 7 days followed by growth in minimal glucose medium. We found that these adapted cells had an EC 50 of 5.3 M, a level of Tu resistance comparable with the cell lines pZJM(THT3Ј) and pZJM(HKORF) that had been induced for RNAi (Fig. 1A) . This finding raised the possibility that Tu or one of its phosphorylated forms directly targets a glycolytic enzyme.
Tu Causes an Increase in the Intracellular Concentration of 1,3-Bisphosphoglycerate, a Glycolytic Intermediate-The glycolytic pathway comprises 10 enzymatic steps that convert each molecule of glucose to two molecules of pyruvate with a net production of two ATP molecules. Of these 10 enzymes, 5 bind adenosine in the form of the phosphorylated nucleosides ADP and ATP or as the co-enzymes NAD ϩ and NADH. We hypothesized that by inhibiting one of these enzymes, Tu, an adenosine analog, might reduce glycolytic flux. We evaluated this possibility by HPLC analysis of the glycolytic intermediates (15) . An analysis of extracts from parental cells treated for 60 min with 25 M, Tu resulted in an increase in a peak that elutes in a position expected for 1,3-bisphosphoglyceric acid (1,3-BPG) (Fig. 3B ). Incubation with 50 and 100 M Tu confirmed that this effect is dose-dependant (data not shown). This peak is also detected in untreated parasites as a shoulder of a peak comigrating with fructose 2,6-bisphosphate (Fig. 3A) . We identified the 1,3-BPG in two ways. First, using this HPLC chromatography system, 1,3-BPG is known to have a retention time between that of fructose 1,6-bisphosphate and fructose 2,6-bisphosphate (15) . The addition of 10 pmol of each of these compounds to the trypanosome extract confirmed that the unknown peak migrates between them (data not shown). Second, we synthesized 1,3-BPG by incubation of glyceraldehyde 3-phosphate with glyceraldehyde-phosphate dehydrogenase, yielding a product with a retention time matching that of the unknown peak (data not shown). 1,3-BPG is a substrate for the seventh enzyme in glycolysis, PGK. The above finding suggested that Tu or a phosphorylated metabolite might cause an increase in the concentration of 1,3-BPG by inhibiting PGK. We found that Tu has no effect on PGK activity in cell extracts, although 1 mM TuMP inhibited activity by 14% (data not shown).
Therefore, we analyzed the impact of Tu nucleotides on purified PGK. T. brucei has three PGK genes, PGKA, PGKB, and PGKC, with PGKB being the dominant form in procyclic cells (16) . We purified recombinant T. brucei PGKB and measured the effect of Tu nucleotides on its activity. To assay PGK, we used a coupled reaction that includes glyceraldehyde-3-phosphate dehydrogenase and monitored oxidation of NADH to NAD ϩ . We found that TuMP inhibits recombinant PGKB with an IC 50 of ϳ25 M. AMP also inhibits PGKB with an IC 50 ϳ 30 M (data not shown). In a similar coupled reaction using yeast PGK, TuMP and AMP had no effect, indicating that the glyceraldehyde-3-phosphate dehydrogenase in the assay is insensitive to both compounds (data not shown). We then tested the effect of TuTP on recombinant PGKB. This molecule inhibits PGKB with an IC 50 ϳ7.5 M (Fig. 4) .
DISCUSSION
It seemed likely when we initiated this project that our library selection would reveal that silencing of a nucleoside transporter would lead to Tu resistance as has been found with Leishmania Tu-resistant mutants (4) . However, since we began these experiments, it was reported that procyclic trypanosomes express at least two independent high affinity adenosine transporters (17), a finding that could explain why we did not identify a nucleoside transporter in our selection. Instead, our RNAi library selection has clarified for the first time a mechanism of Tu toxicity in trypanosomes.
Our selection revealed that silencing of a glucose transporter conferred resistance to toxic levels of Tu, suggesting an unexpected link between glucose metabolism and Tu toxicity. Additional experiments confirmed this link. We found Tu resistance in cells with glycolysis suppressed by RNAi silencing of hexokinase 1 or by adaptation to grow in glucose-depleted medium (in the absence of RNAi). How could Tu target glucose metabolism? It has been well established that some adenosine analogs inhibit trypanosome glycolytic enzymes (18) . The rationale behind this effort is that all but two of these enzymes contain adenosine-binding domains interacting with either NAD(H) or ADP/ATP. We found that parasites treated with Tu had an increase in the glycolytic intermediate 1,3-BPG, suggesting that Tu or phosphorylated Tu inhibited PGK. Trypanosomes compartmentalize the first seven steps of glycolysis in peroxisome-like organelles known as glycosomes (19) . Bloodstream trypanosomes are completely reliant upon glycolysis for energy with both glycolytic flux and glycosome number being greatly increased. In contrast, procyclic trypanosomes utilize several pathways including glycolysis for energy production. Interestingly, procyclic trypanosomes express at least two glycolytic enzymes in the cytosol (1) . One of these, PGKB, is the dominant PGK allele in the procyclic stage (20) . We found that recombinant PGKB is sensitive to TuMP and TuTP in vitro. We did not test TuDP, which might compete even better with the ADP substrate of PGKB. These data along with the observation that 1,3-BPG accumulates in Tu-treated cells suggest that PGKB is inhibited by phosphorylated forms of Tu. We have not ruled out the possibility that Tu toxicity is the result of elevated levels of 1,3-BPG rather than inhibition of glycolysis.
One paradox is how Tu is toxic to procyclic trypanosomes, whereas RNAi silencing of the glucose transporter or growth of these cells in glucose-depleted medium is not. Based on the finding that procyclic trypanosomes can shift their metabolism from a state dependent upon glycolysis (in high glucose medium) to one dependent upon amino acids (in low glucose medium) (14) , we propose that procyclic parasites survive without glycolysis only if they are given time to adapt to a glucose-free environment, a process possibly involving up-regulation of amino acid metabolism or transport. RNAi silencing of the glucose transporter or hexokinase probably occurs over several days, giving time for this adaptation. In contrast, Tu acts quickly, killing the parasites before they can adapt. The fact that depletion of glucose from the culture medium also causes a similar level of Tu resistance (a phenomenon unrelated to RNAi) provides strong evidence that glycolysis is the major target of Tu at the concentrations used in this study.
It is possible that we would identify other genes if we initiated the Tu screen in trypanosomes pre-adapted to amino acid metabolism. Because higher concentrations of Tu are toxic to cells even after adaptation to amino acid metabolism, there must be other pathways also sensitive to Tu.
